Literature DB >> 11073218

A potential RNA drug target in the hepatitis C virus internal ribosomal entry site.

R Klinck1, E Westhof, S Walker, M Afshar, A Collier, F Aboul-Ela.   

Abstract

Subdomain IlId from the hepatitis C virus (HCV) internal ribosome entry site (IRES) has been shown to be essential for cap-independent translation. We have conducted a structural study of a 27-nt fragment, identical in sequence to IlId, to explore the structural features of this subdomain. The proposed secondary structure of IlId is comprised of two 3 bp helical regions separated by an internal loop and closed at one end by a 6-nt terminal loop. NMR and molecular modeling were used interactively to formulate a validated model of the three-dimensional structure of IlId. We found that this fragment contains several noncanonical structural motifs and non-Watson-Crick base pairs, some of which are common to other RNAs. In particular, a motif characteristic of the rRNA alpha-sarcin/ricin loop was located in the internal loop. The terminal loop, 5'-UUGGGU, was found to fold to form a trinucleotide loop closed by a trans-wobble U.G base pair. The sixth nucleotide was bulged out to allow stacking of this U.G pair on the adjacent helical region. In vivo mutational analysis in the context of the full IRES confirmed the importance of each structural motif within IIId for IRES function. These findings may provide clues as to host cellular proteins that play a role in IRES-directed translation and, in particular, the mechanism through which host ribosomes are sequestered for viral function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073218      PMCID: PMC1370013          DOI: 10.1017/s1355838200000935

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  35 in total

1.  Structure of Escherichia coli ribosomal protein L25 complexed with a 5S rRNA fragment at 1.8-A resolution.

Authors:  M Lu; T A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  The scientific challenge of hepatitis C.

Authors:  J Cohen
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

3.  Solution structure of the tobramycin-RNA aptamer complex.

Authors:  L Jiang; D J Patel
Journal:  Nat Struct Biol       Date:  1998-09

4.  A common motif organizes the structure of multi-helix loops in 16 S and 23 S ribosomal RNAs.

Authors:  N B Leontis; E Westhof
Journal:  J Mol Biol       Date:  1998-10-30       Impact factor: 5.469

5.  Structural features of a six-nucleotide RNA hairpin loop found in ribosomal RNA.

Authors:  M A Fountain; M J Serra; T R Krugh; D H Turner
Journal:  Biochemistry       Date:  1996-05-28       Impact factor: 3.162

6.  Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon.

Authors:  J E Reynolds; A Kaminski; A R Carroll; B E Clarke; D J Rowlands; R J Jackson
Journal:  RNA       Date:  1996-09       Impact factor: 4.942

Review 7.  Hepatitis C virus: structure, protein products and processing of the polyprotein precursor.

Authors:  M Houghton; M Selby; A Weiner; Q L Choo
Journal:  Curr Stud Hematol Blood Transfus       Date:  1994

8.  The two faces of the Escherichia coli 23 S rRNA sarcin/ricin domain: the structure at 1.11 A resolution.

Authors:  C C Correll; I G Wool; A Munishkin
Journal:  J Mol Biol       Date:  1999-09-17       Impact factor: 5.469

9.  The loop E-loop D region of Escherichia coli 5S rRNA: the solution structure reveals an unusual loop that may be important for binding ribosomal proteins.

Authors:  A Dallas; P B Moore
Journal:  Structure       Date:  1997-12-15       Impact factor: 5.006

10.  Structure of the P1 helix from group I self-splicing introns.

Authors:  F H Allain; G Varani
Journal:  J Mol Biol       Date:  1995-07-14       Impact factor: 5.469

View more
  45 in total

1.  Geometric nomenclature and classification of RNA base pairs.

Authors:  N B Leontis; E Westhof
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

2.  The internal ribosome entry site (IRES) of hepatitis C virus visualized by electron microscopy.

Authors:  L P Beales; D J Rowlands; A Holzenburg
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

3.  Structural organization of a viral IRES depends on the integrity of the GNRA motif.

Authors:  Olga Fernández-Miragall; Encarnación Martínez-Salas
Journal:  RNA       Date:  2003-11       Impact factor: 4.942

4.  A plant virus replication system to assay the formation of RNA pseudotriloop motifs in RNA-protein interactions.

Authors:  P C Joost Haasnoot; John F Bol; René C L Olsthoorn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

5.  Ribosomal proteins mediate the hepatitis C virus IRES-HeLa 40S interaction.

Authors:  Geoff A Otto; Peter J Lukavsky; Alissa M Lancaster; Peter Sarnow; Joseph D Puglisi
Journal:  RNA       Date:  2002-07       Impact factor: 4.942

6.  SCOR: Structural Classification of RNA, version 2.0.

Authors:  Makio Tamura; Donna K Hendrix; Peter S Klosterman; Nancy R B Schimmelman; Steven E Brenner; Stephen R Holbrook
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

7.  Inhibitor RNA blocks the protein translation mediated by hepatitis C virus internal ribosome entry site in vivo.

Authors:  Xue-Song Liang; Jian-Qi Lian; Yong-Xing Zhou; Mo-Bin Wan
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

8.  Structure of the three-way helical junction of the hepatitis C virus IRES element.

Authors:  Jonathan Ouellet; Sonya Melcher; Asif Iqbal; Yiliang Ding; David M J Lilley
Journal:  RNA       Date:  2010-06-25       Impact factor: 4.942

Review 9.  Searching for IRES.

Authors:  Stephen D Baird; Marcel Turcotte; Robert G Korneluk; Martin Holcik
Journal:  RNA       Date:  2006-09-06       Impact factor: 4.942

10.  A long-range RNA-RNA interaction between the 5' and 3' ends of the HCV genome.

Authors:  Cristina Romero-López; Alfredo Berzal-Herranz
Journal:  RNA       Date:  2009-07-15       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.